2825 Airview Boulevard
178 articles with Stryker
Stryker Teams Up With Jerome Bettis and Fred Funk to Celebrate the Selection of the "Get on the Bus" Contest Winner in New Jersey
Today, Stryker's Joint Replacement Division announced the third and final winner of its "Get on the Bus" contests - aimed at encouraging people living with joint pain to see a healthcare professional to learn about treatment options and take the first steps to a healthier lifestyle.
KFx Medical, LLC. announced it has sued Stryker, Inc. (NYSE: SYK) for its continued infringement of US Patent number 7,585,311 and related patents for knotless double row rotator cuff repair.
Physio-Control Receives Premarket Approval From the FDA On Its Full Portfolio of LIFEPAK® Professional Devices
Physio-Control, now part of Stryker, today announced it has received premarket approval by the U.S. Food and Drug Administration (FDA) to continue to market and distribute its full line of LIFEPAK professional defibrillators in the U.S.
Stryker and Fred Funk Host Second "Get on the Bus" Contest Winner in Jacksonville to Promote Importance of Joint Health
Stryker's Joint Replacement Division announced the second winner of its "Get on the Bus" contests
Stryker And Jerome Bettis Host First-Ever "Get On The Bus" Contest Winner In Pittsburgh To Promote Importance Of Joint Health
Stryker's Joint Replacement Division announced the first winner of its "Get on the Bus" contests
The medical device market was about $521.2 billion last year and is projected to hit $674.5 billion by 2022. Here’s a look at the top 10 medical device companies in the world this year.
Stryker’s Spine division will showcase its expanding line of Tritanium® cages, including the new Tritanium® TL Curved Posterior Lumbar Cage, a 3D-printed interbody fusion cage intended for use as an aid in lumbar fixation, at the American Association of Neurological Surgeons (AANS) Annual Scientific Meeting, April 28–May 2, 2018, in New Orleans.
During a meeting with U.S. Food and Drug Administration Commissioner Scott Gottlieb earlier this week, government and healthcare officials in New Jersey highlighted the need to hasten the approval of new drugs and permanently eliminate the tax on medical devices.
Stryker to showcase its groundbreaking Target Guided Surgery navigation system at the Combined Otolaryngology Spring Meetings
Stryker announced today that it will feature its new Target Guided Surgery (TGS®) navigation system at the Combined Otolaryngology Spring Meetings (COSM), taking place in National Harbor, Maryland, April 18-22.
Stryker Launches Campaign Challenging Those Suffering From Joint Pain to "Get on the Bus" to a Healthier Lifestyle
Stryker enlists help of ambassadors Jerome "The Bus" Bettis and Fred Funk to get folks on board in 2018
Stryker's Instruments division announced today the launch of the Stryker F1™ Small Bone Power System, providing surgeons with a cordless, balanced, lightweight solution for procedures of the extremities.
Tritanium C Anterior Cervical Cage Implanted By More Than 300 Surgeons Since Late-October Launch
Stryker’s Spine Division Receives FDA Clearance for 3D-Printed Tritanium TL Curved Posterior Lumbar Cage
Stryker’s Spine division today announced that its Tritanium® TL Curved Posterior Lumbar Cage, a 3D-printed interbody fusion cage intended for use as an aid in lumbar fixation, recently received 510(k) clearance from the U.S. Food and Drug Administration.
System features Trident II Tritanium, building on Trident brand legacy, combining the reproducibility of AMagine™ additive manufactured Tritanium® In-Growth Technology with the precision of Mako Robotic-Arm Assisted Surgery
Stryker introduces groundbreaking, post-free distraction system, designed to mitigate common groin complications associated with hip arthroscopy
Stryker announced today the launch of the industry's first-ever, post-free hip distraction system, Pivot Guardian, designed to mitigate groin complications and heel slip associated with hip arthroscopy and improve patient outcomes.
2/16/2018The expanded indication of Stryker's clot-removal device is in line with the new AHA/ASA guidelines.
The new recommendation expanded the treatment window from six to 16 hours based on overwhelming clinical evidence.
Stryker's WEAVE Trial Demonstrates Positive Results of Endovascular Treatment for Patients With Intracranial Atherosclerotic Disease
Stryker's sponsored WEAVE Trial is a multi-center, prospective, post-market surveillance study designed to evaluate the rate of stroke or death within 72 hours of the procedure in patients treated with the Wingspan Stent System.
Today, 3D Systems and Stryker announced an exclusive distribution partnership for VSP and anatomical models for the craniomaxillofacial specialty.
Here's a look at the seven best life science companies to work for in 2018.